KUWAIT: A local daily reported yesterday that the AstraZeneca-Oxford vaccine will soon be approved and first shipments may arrive in Kuwait next week with 200,000 doses initially, which will reach 800,000 by February and the start of March. Al-Qabas newspaper quoted sources who said that the import is linked to approval time as the vaccine must be registered first before preparing to receive it.

Advantages of the AstraZeneca vaccine include easy storage, as it requires storage temperatures of only two to eight degrees Celsius, compared to others that require a temperature of -70 degrees Celsius. This will enable the vaccination of most members of the society, while the vaccine fights new COVID-19 variants too.